Literature DB >> 28596003

Empty follicle syndrome revisited: definition, incidence, aetiology, early diagnosis and treatment.

Alberto Revelli1, Andrea Carosso2, Giuseppina Grassi2, Gianluca Gennarelli2, Stefano Canosa2, Chiara Benedetto2.   

Abstract

In this review, the definition, incidence and possible causes of empty follicle syndrome (EFS), including molecular mechanisms that may underlie the syndrome, are discussed, along with prevention and treatment options. EFS is the complete failure to retrieve oocytes after ovarian stimulation, despite apparently normal follicle development and adequate follicular steroidogenesis. Two variants of EFS have been described: the 'genuine' form (gEFS), which occurs in the presence of adequate circulating HCG levels at the time of oocyte aspiration, and the 'false' form (f-EFS), which is associated with circulating HCG below a critical threshold. Heterogeneous HCG concentration thresholds, however, have been used to define gEFS, and to date no standardization exist. The situation is unclear when GnRH-analogues are used for ovulation trigger, as the threshold circulating LH and progesterone levels used to define EFS as 'genuine' are not established. The cause of fEFS has been clearly identified as an error in HCG administration at the time of ovulation trigger; in contrast, the cause of gEFS is still unclear, although some pathogenetic hypotheses have been proposed. Optimal treatment and prognosis of these patients are still poorly understood. Large, systematic multi-centre studies are needed to increase the understanding of EFS.
Copyright © 2017 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  In-vitro fertilization; Oocyte retrieval; Ovarian follicle; Ovarian stimulation; Ovulation trigger

Mesh:

Substances:

Year:  2017        PMID: 28596003     DOI: 10.1016/j.rbmo.2017.04.012

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  12 in total

Review 1.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

2.  A novel homozygous nonsense ZP1 variant causes human female infertility associated with empty follicle syndrome (EFS).

Authors:  Qianhua Xu; Xiaoli Zhu; Madiha Maqsood; Wenqing Li; Xianhong Tong; Shuai Kong; Fengsong Wang; Xiaoman Liu; Zhaolian Wei; Zhiguo Zhang; Fuxi Zhu; Yunxia Cao; Jianqiang Bao
Journal:  Mol Genet Genomic Med       Date:  2020-04-23       Impact factor: 2.183

3.  Empty Follicle Syndrome: A Challenge to Physician.

Authors:  Neeta Singh; Venus Dalal; Alka Kriplani; Neena Malhotra; Reeta Mahey; Vanamail Perumal
Journal:  J Hum Reprod Sci       Date:  2018 Jul-Sep

4.  Evaluation of follicular fluid's Beta-Human chorionic gonadotropin in the follicles of patient undergoing Intracytoplasmic sperm injection: A cross-sectional study.

Authors:  Masoumeh Hajshafiha; Tahere Behrouzi Lak; Nasrin Hajiloo; Yaghoub Deldar; Mina Ghorbani; Fedyeh Haghollahi
Journal:  Int J Reprod Biomed       Date:  2019-01-28

5.  Case Report: A Novel Heterozygous ZP3 Deletion Associated With Empty Follicle Syndrome and Abnormal Follicular Development.

Authors:  Yongzhe Chen; Zesong Wang; Yueren Wu; Wenbin He; Juan Du; Sufen Cai; Fei Gong; Guangxiu Lu; Ge Lin; Can Dai
Journal:  Front Genet       Date:  2021-05-19       Impact factor: 4.599

6.  Self-Detection of the LH Surge in Urine After GnRH Agonist Trigger in IVF-How to Minimize Failure to Retrieve Oocytes.

Authors:  Mauro Cozzolino; Sonia Matey; Abigail Alvarez; Mónica Toribio; Verónica López; Marta Perona; Elizabet Henzenn; Manuel Piró; Peter Humaidan; Juan A Garcia-Velasco
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-21       Impact factor: 5.555

7.  Borderline form of empty follicle syndrome treated with a novel dual trigger method combined with delayed oocyte retrieval: A case report.

Authors:  Xian-Ling Cao; Zhen-Gao Sun
Journal:  World J Clin Cases       Date:  2020-02-26       Impact factor: 1.337

Review 8.  Gonadotropin-releasing hormone agonist ovulation trigger-beyond OHSS prevention.

Authors:  Juan Carlos Castillo; Thor Haahr; María Martínez-Moya; Peter Humaidan
Journal:  Ups J Med Sci       Date:  2020-03-25       Impact factor: 2.384

9.  Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF.

Authors:  Andrea Roberto Carosso; Stefano Canosa; Gianluca Gennarelli; Marta Sestero; Bernadette Evangelisti; Lorena Charrier; Loredana Bergandi; Chiara Benedetto; Alberto Revelli
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-07

10.  Expectant Management Before In vitro Fertilization in Women Aged 39 or Above and Unexplained Infertility Does Not Decrease Live Birth Rates Compared to Immediate Treatment.

Authors:  Andrea Roberto Carosso; Rik van Eekelen; Alberto Revelli; Stefano Canosa; Noemi Mercaldo; Ilaria Stura; Stefano Cosma; Carlotta Scarafia; Chiara Benedetto; Gianluca Gennarelli
Journal:  Reprod Sci       Date:  2021-11-01       Impact factor: 2.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.